Reply

Affiliations

¹ aDepartment of Medicine, University of Padova, Padua, Italy bDivision of Hypertension, University of Michigan, Ann Arbor, Michigan, USA cCentro Interuniversitario di Fisiologia Clinica e Ipertensione, University of Milan, Ospedale Maggiore and Istituto Auxologico Italiano, Milan, Italy.

Comment

Paolo Palatini et al. J Hypertens. 2016 Oct.

. 2016 Oct;34(10):2103-4.

doi: 10.1097/HJH.0000000000001055.

¹ aDepartment of Medicine, University of Padova, Padua, Italy bDivision of Hypertension, University of Michigan, Ann Arbor, Michigan, USA cCentro Interuniversitario di Fisiologia Clinica e Ipertensione, University of Milan, Ospedale Maggiore and Istituto Auxologico Italiano, Milan, Italy.

No abstract available

Comment on

Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension.
Palatini P, Rosei EA, Casiglia E, Chalmers J, Ferrari R, Grassi G, Inoue T, Jelakovic B, Jensen MT, Julius S, Kjeldsen SE, Mancia G, Parati G, Pauletto P, Stella A, Zanchetti A. Palatini P, et al. J Hypertens. 2016 May;34(5):813-21. doi: 10.1097/HJH.0000000000000865. J Hypertens. 2016. PMID: 26982382
Heart rate lowering by beta-blockade and cardiovascular events.
Messerli FH, Rimoldi SF, Bangalore S. Messerli FH, et al. J Hypertens. 2016 Oct;34(10):2102-3. doi: 10.1097/HJH.0000000000001056. J Hypertens. 2016. PMID: 27579706 No abstract available.